Methyl 2-bromo-3-hydroxybenzoate
- Catalog NO.：A930446
- CAS No. : 1260783-82-1
- Molecular Formula：C8H7BrO3
- Molecular Weight： 231.04
1. Please click the
to confirm the discount and stock quantity.2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
| CAS Number | 1260783-82-1 | Appearance | Light brown powder |
| Catalog Number | A930446 | MDL Number | MFCD10566795 |
| Molecular Formula | C8H7BrO3 | Molecular Weight | 231.04 |
| Boiling Point | Melting Point | ||
| Flash Point | Density | ||
| Synonyms | Methyl 2-bromo-3-hydroxybenzoate | ||
| Storage Condition | Store in a tightly closed container,in a cool and dry place | ||
Safety
| GHS Pictogram |
|
||
| Signal Word | Warming | UN Number | |
| Hazard Statements | H302;H315;H319;H335 | Class | |
| Precautionary Statements | P261;P305+P351+P338 | Packing Group | |
Description
|
Talazoparib, also known as BMN-673 and MDV-3800, is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity (PARP1 IC50 = 0.57 nmol/L). Talazoparib acts as an inhibitor of poly ADP ribose polymerase(PARP) which aids in single strand DNA repair. Cells that have BRCA1/2 mutations are susceptible to the cytotoxic effects of PARP inhibitors because of an accumulation of DNA damage. Talazoparib is theorized to have a higher potency than olaparib due to the additional mechanism of action called PARP trapping. PARP trapping is the mechanism of action where the PARP molecule is trapped on the DNA, which interferes with the cells ability to replicate. Talazoparib is found to be ~100 fold more efficient in PARP trapping than olaparib. |
